We employed intracoronary infusion of adenosine deaminase to test the hypothesis that endogenous adenosine contributes to regulation of coronary blood flow following acute reductions in coronary artery pressure. In 16 closed-chest anesthetized dogs, we perfused the left circumflex coronary artery from a pressurized arterial reservoir and measured coronary blood flow following changes in perfusion pressure before and 10 minutes after the start of intracoronary adenosine deaminase, 5 U/min per kg body weight. Parallel studies showed that this dose of enzyme resulted in cardiac lymph adenosine deaminase concentrations of 3.2 ± 0.4 U/ml. Adenosine deaminase abolished the vasodilator response to intracoronary adenosine, 4 and 8 /tg, but had no effect on the vasodilator response to intracoronary papaverine, 200 and 300 ^g, demonstrating enzyme efficacy and specificity. Additional experiments demonstrated that adenosine deaminase reversibly attenuated myocardial reactive hyperemia following 5-and 10-second coronary occlusions by 30% (P < 0.05), evidence that the infused enzyme effectively degraded endogenous adenosine. However, adenosine deaminase did not alter the time course for coronary autoregulation or the steady state autoregulatory flow response over the pressure range between 125 and 75 mm Hg. Further, adenosine deaminase did not alter steady state coronary flow when perfusion pressure was reduced below the range for effective autoregulation (60-40 mm Hg). Such results show that adenosine is not essential for either coronary autoregulation or for the maintenance of coronary vasodilation when autoregulatory vasodilator reserve is expended. (CircRes 56: 517-524, 1985) 
CORONARY autoregulation is the intrinsic ability of the heart to maintain its blood supply relatively constant in the face of fluctuations in perfusion pressure (Mosher et al., 1964; Cross, 1964) . The mechanism underlying this fundamental adaptive flow response is unknown. According to the metabolic hypothesis, coronary autoregulation is initiated by flow-dependent changes in tissue levels of a metabolic substrate or a metabolite (Johnson, 1964; Rubio and Berne, 1975; Belloni, 1979; Feigl, 1983) . Several studies have demonstrated increased adenosine production and release during conditions in which oxygen supply is reduced (Katori and Berne, 1966; Rubio and Berne, 1969; Rubio et al., 1974; . In one of these studies , tissue adenosine content and adenosine release increased when perfusion pressure was lowered over the autoregulation range in isolated buffer-perfused guinea pig hearts. As the investigators point out, such a correlation only suggests, but does not prove, that adenosine is the primary determinant of changes in coronary resistance during autoregulation.
This study tests the hypothesis that endogenous This manuscript from the University of Iowa was sent to John T. Shepherd, Consulting Editor, for review by expert referees, for editorial decision, and final disposition. adenosine is an essential mediator of coronary autoregulation. The hypothesis predicts that destroying interstitial adenosine should abolish autoregulation. Extending this inquiry to pressures below the autoregulation range tests a second hypothesis, namely, that endogenous adenosine mediates coronary flow only when autoregulatory vasodilator reserve is expended. In both sets of experiments, an intracoronary infusion of adenosine deaminase was used to destroy interstitial adenosine. Adenosine deaminase did not alter coronary pressure-flow relationships in either instance, new evidence that adenosine is not essential for coronary autoregulation.
The hematocrit averaged 38 ± 2%. Systemic pressure was measured in the aorta with a catheter passed retrograde from the femoral artery and a strain gauge pressure transducer. Rectal temperature was held at 37°C with heating pads. Heart rate was measured continuously with a cardiotachometer triggered from the electrocardiogram.
Coronary Perfusion System
Pressure in the circumflex artery was controlled by an extracorporeal perfusion circuit (Dole et al., 1981) . The circumflex artery was perfused from a pressurized arterial reservoir through a metal cannula advanced through the right carotid artery into the ascending aorta and wedged in the proximal circumflex artery under pressure and flow monitoring as described by Smith et al. (1974) . The reservoir was heated to maintain the temperature of the blood entering the cannula at 37°C. Coronary artery pressure was measured at the cannula tip through an external auxiliary tube opening at the distal end of the perfusion cannula. Blood passed from the reservoir through an electromagnetic flow probe before entering the coronary cannula. The pressure in the reservoir was controlled by means of two compressed air tanks connected in parallel, permitting arbitrary alterations in perfusion pressure. The seal between the cannula tip and circumflex artery was confirmed by observing the response of cannula tip pressure to inflow occlusion and by injecting saturated Evans blue solution into the coronary cannula at the end of the experiment as described previously (Dole et al., 1981) . The dye injection also served to delineate the area of perfused myocardium which was removed and weighed in order to calculate coronary flow per unit of muscle mass. Blood coagulation in the extracorporeal perfusion circuit was prevented by infusion of sodium heparin (initial dose 500 U/kg, iv, then 250 U/kg, iv, every hour). The flow meter zero was determined by frequent coronary inflow occlusions. The flow probe was calibrated by timed blood volume collections after each experiment with blood from the experimental animal.
We have previously shown that this perfusion system does not alter systemic hemodynamics. Furthermore, coronary reactive hyperemia and autoregulation are not impaired with the cannula in place (Dole et al., 1981) .
Penetration of 131 I-Adenosine Deaminase into Cardiac Inters titium
Experiments in five dogs evaluated the concentration of 131 I-adenosine deaminase in cardiac lymph during the intracoronary infusion of this enzyme. In these experiments, we used mongrel dogs anesthetized with sodium thiamylal, 18 mg/kg, iv, and maintained in surgical anesthesia by ventilation with O 2 -enriched air containing 0.5% halothane. Surgical preparation entailed thoracotomy through the left 5th intercostal space to expose the heart for the transepicardial insertion of a 20-gauge angiocath into the left anterior descending coronary artery near its origin. A C-shaped piece of PE 10 tubing about 5 cm long was inserted into a lymphatic channel coursing over the left anterior descending coronary artery. Cyanoacrylate cement anchored both catheters. The experiments consisted of the intracoronary infusion of 131 I-adenosine deaminase, (Daddona' and Kelley, 1977) , specific activity 2950-3700 counts/min per U, for 20 minutes at a rate of 5 U/min per kg body weight. During the 131 I-adenosine deaminase infusion and for up to 30 minutes after its completion, we collected serial samples of lymph directly Circulation Research/Vol. 56, No. 4, April 1985 into capillary tubes certified to contain 50 ± 1 fi\. The 131 I activity in this lymph and the I31 I and enzymatic activity of the infusate served for calculation of lymph adenosine deaminase (ADA) concentration by the formula: lymph ADA (U/ml) = infusate ADA (U/ml) X lymph 131 I (counts/min per ml) infusate 131 I (counts/min per ml)
Since the assay of adenosine deaminase activity is carried out at 25°C, but the cardiac interstitium is at 37°C, we compared initial rates of deamination of 0.1 HIM adenosine at these two temperatures. At 37°C, the catalytic activity of adenosine deaminase was 1.95 times higher than the activity at 25°C.
Functional Activity of Adenosine Deaminase
Calf intestinal adenosine deaminase, type I, was obtained from Sigma as a suspension in 3.2 M (NH 4 ) 2 SO4, pH 6. The enzyme solution for intracoronary infusion consisted of 4000 U adenosine deaminase and 12 mmol Na 2 HPO 4 in a total volume of 30 ml 0.14 M NaCl. The pH of the enzyme solution was 7.4. This solution was filtered through a 0.44-/xm cellulose acetate membrane immediately prior to use. A solution containing the same proportions of (NH 4 ) 2 SO 4 and Na 2 HPO 4 in 0.14 M NaCl was infused into the coronary circulation during all control observations.
Two tests assessed the functional enzymatic activity of the adenosine deaminase. First, we determined the vasodilator response to a 4-and 8-^g intracoronary bolus of adenosine before, during, and at 120 minutes after the end of the adenosine deaminase infusion. Such a test ensures that the adenosine deaminase is catalytically active in our preparation. Second, we measured reactive hyperemic flow responses following 2-, 5-, and 10-second coronary inflow occlusions before, during, and at 60 minutes after discontinuing the adenosine deaminase infusion. The order of occlusions was randomized and each observation was the average of two occlusions for each duration. Occlusions were separated by at least 3 minutes. Such a test documents the penetration of the enzyme into the cardiac interstitial space. To allow the enzyme time to penetrate into the cardiac interstitium, all experimental observations began 10 minutes after the start of the adenosine deaminase infusion.
We assessed the specificity of adenosine deaminase for adenosine in four animals by comparing the effects of intracoronary injections of adenosine and papaverine before and during adenosine deaminase infusion. Attenuation of coronary vasodilator responses to adenosine but not to papaverine would provide evidence for enzyme specificity.
Since attenuation of vasodilator responses to intracoronary adenosine by adenosine deaminase could be due to exogenous enzyme in the blood, in five animals we compared vasodilator responses in the coronary bed to those in the femoral bed before, during, and at 120 minutes after discontinuing the infusion of the enzyme. Selective inhibition of adenosine-induced vasodilation in the coronary bed would indicate that the effect of adenosine deaminase was due to enzyme retained in the heart and not to enzyme in the blood which should affect adenosine responses in both the femoral and coronary beds. In these experiments, the left femoral artery was cannulated and perfused through an extracorporeal circuit with blood from the dog's left common carotid artery. The circuit contained an in-line electromagnetic flow probe for measuring femoral blood flow.
Experimental Protocol
After the preparation had stabilized for 30-45 minutes, we recorded control heart rate, mean aortic pressure, coronary blood flow at a coronary perfusion pressure of 100 mm Hg, the coronary flow response to intracoronary adenosine, the coronary flow response to intracoronary papaverine, coronary reactive hyperemia after 2-, 5-, and 10-second inflow occlusions, and coronary artery pressure-flow curves. In nine animals, steady state coronary flow was determined at pressures of 125, 100, and 75 mm Hg. In seven of these animals, the dynamic flow response to a step changes in pressure between 125 and 75 mm Hg was also recorded. In seven separate animals, steady state coronary artery pressure-flow relationships were obtained over the range of 100-40 mm Hg by decreasing pressure in 20 mm Hg steps. Flow was allowed to stabilize at least 2 minutes between each pressure change.
Following control measurements, adenosine deaminase was infused into the circumflex coronary bed at a rate sufficient to deliver 5 U/min per kg. At the 10th minute of enzyme infusion, we repeated all of the experimental observations. The adenosine deaminase infusion then was stopped and a final set of measurements of all experimental parameters was obtained 1 hour later. The responses to intracoronary injections of adenosine were also recorded at 120 minutes after infusion was discontinued.
At the completion of the experiment, Evans blue was injected into the perfusion cannula at the maximum coronary artery pressure used during the experiment, and the animal was killed by intravenous injection of saturated potassium chloride. The heart then was removed and the stained area weighed.
Quantification of Autoregulation
The degree of autoregulation was quantified by calculating the closed loop gain of the system (Norris et al., 1979) as
where F is the steady state flow at pressure P, and AF is the change in flow for a given change in pressure AP. Values for G A greater than zero indicate the degree of autoregulation with a maximum value of 1. Values of G A < 0 indicate a lack of autoregulation, i.e., a passive vascular bed.
We characterized the time course of the autoregulatory response by measuring tv,, the time for mean coronary flow to return 50% of the way to control after a step change in pressure, and also by measuring the time for flow to reach a steady state.
Data Analysis
Hemodynamic data before and after adenosine deaminase were compared by Student's f-test for paired observations. Differences in pressure-flow data, responses to drugs, and reactive hyperemic flow responses before, during, and after adenosine deaminase were assessed by analysis of variance and Tukey's test for multiple comparisons (Snedecor and Cochran, 1980) .
Reactive hyperemic flow-defined as the volume of flow greater than control flow rate-and peak reactive hyperemic flow were determined, and the data from two occlusions for each duration were averaged and expressed as a percent change from the control response.
Differences between means were considered to be statistically significant when P was less than 0.05. All data are expressed as mean ± SEM.
Results
Control hemodynamic parameters for all 16 animals at a circumflex perfusion pressure of 100 mm Hg were: heart rate 132 ± 7 beats/min, mean aortic pressure 115 ± 6 mm Hg, and mean coronary flow 78 ± 3 ml/min per 100 g. The corresponding values during infusion of adenosine deaminase were 128 ± 8 beats/min, 116 ± 6 mm Hg, and 77 ±3 ml/min per 100 g; at 60 minutes after discontinuing adenosine deaminase, they were 130 ± 8 beats/min, 113 ± 8 mm Hg, and 80 ± 4 ml/min per 100 g. These changes are not significant. Figure 1 shows the effects of adenosine deaminase on steady state coronary flow over the pressure range of 125 to 75 mm Hg in nine animals. Control flow averaged 80 ml/min per 100 g at a pressure of 100 mm Hg and was not altered by adenosine deaminase. The autoregulatory gain for a step reduction in pressure from 125 to 100 mm Hg averaged 0.53 ± 0.04 during the control period prior to adenosine deaminase and 0.50 ± 0.05 during adenosine deaminase infusion. These values were not significantly different. The control gain for a reduction in pressure from 100 to 75 mm Hg averaged 0.56 ± 0.06 and was not altered during adenosine deaminase infusion (G A = 0.58 ± 0.06). Figure 2 shows the effects of adenosine deaminase on the coronary flow response to a step change in pressure between 125 and 75 mm Hg. Following a reduction in pressure, coronary flow initially decreased and then returned toward control, reaching a new steady state within 36 seconds. Following an increase in pressure, coronary flow rose transiently and then declined, reaching a new steady state within 25 seconds. Table 1 summarizes the effects of adenosine deaminase on the rime course of coronary autoregulation in seven animals. Adenosine deaminase did not affect the dynamic flow response to a pressure change in either direction. Figure 3 shows the effects of adenosine deaminase on steady state coronary flow responses to 20 mm Hg reductions in pressure over the range between 100 and 40 mm Hg in seven animals. Whereas there was no difference in control flow when pressure was reduced from 100 to 80 mm Hg, pressure reductions below 80 mm Hg resulted in a progressive decrease in flow. Adenosine deaminase did not alter Vol. 56, No. 4, April 1985 Results are expressed as mean ± SEM, n = 7. Abbreviatons: AP, step change in pressure; ADA, adenosine deaminase; ti/2, time for flow to return 50% of the way to control after AP.
Effects of Adenosine Deaminase on Coronary Autoregulation

Effects of Adenosine Deaminase on Coronary Pressure Flow Relations below the Autoregulatory Range
the flow response to pressure change even at pressures below the autoregulation range. Figure 4 plots the degree of autoregulation expressed as the gain, GA, for each pressure step before and during adenosine deaminase infusion. There was a decrease in the degree of autoregulation when initial pressure was lowered from 100 to 80 mm Hg. Between 60 and 40 mm Hg, autoregulation was totally abolished, as indicated by the negative gain. Despite the progressive reduction in the degree of autoregulation, adenosine deaminase had no effect on the flow response to pressure change.
Cardiac Lymph 131 I-Adenosine Deaminase
Lymph flow rate varied between about 6 and 20 /il/min as judged by the time necessary to fill a 50-/xl capillary pipette. Accordingly, the number of lymph samples collected during the 20 minutes of I-adenosine deaminase infusion was three in 2 dogs, five in 2 dogs, and eight in 1 dog. As shown in Figure 5 , lymph I31 I-adenosine deaminase activity rose throughout the period of infusion, reaching an average value of 3.2 ± 0.4 U/ml (range 2.2-4.5 U/ ml). The time course of lymph 131 I-adenosine deaminase activity showed an initial rapid rise followed by an asymptotic approach to the maximum 
FIGURE 4. Effects of adenosine deaminase (ADA) on the autoregulatory gain G*, for 20 mm Hg reductions in perfusion pressure over the range between 100 and 40 mm Hg. Closed bars indicate pre-ADA control values. Open bars indicate values during ADA infusion. ADA had no effect on C A despite a progressive reduction in the degree of autoregulation at the lower initial pressures. Values are mean ± SEM, n=7.
value. Thus, by the 10th minute of enzyme infusion, lymph 131 I-adenosine deaminase concentration averaged 84% of maximum (range 74-95%). Lymph 131 I activity declined rapidly after the end of the enzyme infusion, but levels were still appreciable, approximately 0.5 U/ml, 20 minutes later (data not shown). Figure 6 (panels A and B) summarizes the effects of adenosine and papaverine in the coronary bed before, during, and after intracoronary administration of adenosine deaminase. During control conditions, adenosine (4 and 8 ^g) increased coronary flow by 124 ± 9% and 200 ± 24%, respectively. Adenosine deaminase totally abolished the vasodilator response to intracoronary adenosine during the enzyme infusion and for as long as 120 minutes after discontinuing the enzyme infusion. Papaverine in doses of 200 and 300 ^g increased control coronary flow by 90 ± 15% and 120 ± 22%, respectively. The coronary vasodilator response to papaverine was unchanged during infusion of adenosine de- aminase, demonstrating enzyme specificity. The intra-arterial injection of 10-and 20-^g doses of adenosine into the femoral bed increased mean femoral flow by 79 ± 14% and 118 ± 14%, respectively. In contrast to responses in the coronary bed, the vasodilator response to adenosine in the femoral bed (Fig. 6, panel C) was attenuated only during the enzyme infusion, and returned to control levels 120 minutes after the enzyme infusion was stopped. Thus, the prolonged inhibition of adenosine-induced coronary vasodilation was not due to adenosine deaminase still circulating in the blood, but rather reflected the action of residual enzyme in the heart.
Functional Activity of Adenosine Deaminase
The effects of adenosine deaminase on coronary reactive hyperemia are summarized in Table 2 . During control conditions, the ratio of peak reactive hyperemic flow to basal flow averaged 1.5 ± 0.1 for 2-second occlusions, 2.4 ± 0.1 for 5-second occlusions, and 3.3 ± 0.3 for 10-second occlusions. Peak reactive hyperemic flow was modestly reduced (10%, P < 0.05) only with 5-second occlusions. Adenosine deamimse reduced reactive hyperemic flow by approximately 30% (P < 0.05) following 5and 10-second coronary occlusions and by 8% (P < 0.05) following 2-second occlusions. ADA (closed bars), during ADA  (open bars), and 120 minutes after stopping ADA (stippled bars) . During ADA -2 ± 2 -10 ± 3 * -2 ± 2
FIGURE 6. Functional enzymatic activity of intracoronary adenosine deaminase (ADA). Panel A: coronary flow responses to intracoronary adenosine expressed as percent change. Closed bars indicate pre-ADA control values. Open bars indicate values during ADA infusion. Stippled bars indicate values obtained 120 minutes after stopping the ADA infusion. Values are mean ± SEM, n = 16.* Significantly different from respective control responses, P < 0.05. Panel B: coronary flow responses to intracoronary papaverine before ADA (closed bars), during ADA (open bars), and 120 minutes after stopping ADA (stippled bars). Panel C: femoral flow responses to intra-arterial injections of adenosine before intracoronary
After ADA (60 min) 0 ± 1 -4 ± 3$ -2 ± 2 RHflow (%A from control)
During
After ADA ADA (60 min) -8 ± 3* -3 ± 5 -29 ± 3't -12 ± 2*t -32 ± 3*t -17 ± 5*i
Results are expressed as mean ± SEM, n = 9. Abbreviations: RH, reactive hyperemia; ADA, adenosine deaminase.
* Significantly different from zero, P < 0.05. f Significantly different from 2-second occlusion during ADA, P<0.05.
X Significantly different from corresponding values during ADA, P < 0.05.
Discussion
The major finding in this study is that intracoronary infusion of adenosine deaminase at a concentration sufficient to attenuate myocardial reactive hyperemia did not affect the coronary artery pressure-flow relationship when pressure was reduced over the autoregulation range or to levels even below this range.
Additional experiments demonstrated that adenosine deaminase was efficacious, selective, and had penetrated into the cardiac interstitial space. An intracoronary infusion of the enzyme abolished the coronary vasodilator response to adenosine but did not alter the response to papaverine, evidence of enzyme efficacy and specificity. Further, a comparison of the vasodilator responses to exogenous adenosine in the coronary and femoral beds 2 hours after the intracoronary adenosine deaminase infusion had been discontinued showed that the coronary response was still markedly attenuated, whereas the femoral response was fully restored. This finding indicated that suppression of the coronary response resulted from enzyme retained in the heart rather than from enzyme in the blood. The observation that adenosine deaminase attenuated myocardial reactive hyperemia following 5-and 10-second occlusions by 30%, provides functional evidence that infused enzyme penetrated into the cardiac interstitium. Finally, the studies of 131 I-adenosine deaminase confirm quantitatively that during intracoronary adenosine deaminase infusion, substantial amounts of the enzyme penetrate into the cardiac inters titium.
The collection of lymph from an epicardial lymphatic channel probably is the most direct way to probe the composition of the interstitial space of the perfusion field receiving 131 I-adenosine deaminase. Unlike lymph sampled at more remote sites, the lymph is unlikely to be diluted by lymph draining from regions not receiving enzyme directly, and thus more nearly represents the true value. Nevertheless, we believe that our measurements of lymph aden-Circulation Research/Vol. 56, No. 4, April 1985 osine deaminase concentration are a minimum estimate of the catalytic activity of the enzyme in the interstitial space. Owing to the transit time of 131 Iadenosine deaminase from the interstitium to the sampling site and the averaging effect of sample collections lasting several minutes, the concentration in lymph at any moment will be less than that in the interstitium. Additionally, lymph adenosine deaminase activity does not reflect the extent to which enzyme binds to adenosine deaminase binding proteins (Daddona and Kelley, 1977; Schrader and Stacy, 1977) on the surface (Kornfield, 1983) of the cells which constitute the boundary of the interstitial space. Adenosine deaminase thus bound retains catalytic activity and augments that of enzyme in solution. Finally adenosine deaminase activity is, by convention, measured at 25°C. The catalytic activity in interstitium at 37°C was 1.95 times higher.
The use of adenosine deaminase to probe the participation of adenosine in coronary autoregulation raises a critical question: Does enough enzyme penetrate into the interstitial space to destroy adenosine as fast as it is formed? We do not know of a method for directly measuring the rate of release of adenosine into the cardiac interstitium. However, it is possible to calculate how much adenosine production would have to increase in order to maintain adenosine concentrations constant in the presence of adenosine deaminase. Such calculations make allowances for the temperature differential between the cardiac interstitium and the in vitro assay, assume that the interstitial space volume is 0.217 ml/g (Frank and Langer, 1974) , and accept the basal interstitial adenosine concentration of 0.2 /IM (Olsson et al., 1982) . To maintain the adenosine concentration of 0.2 /iM in the presence of 3.2 U adenosine deaminase per ml, the average of our measurements, adenosine production would have to increase substantially by 9.3 nmol/min per g of left ventricle. Because, under these conditions, the enzyme is operating at a substrate concentration of only 0.7% of Km, any increase in the rate of adenosine production will elicit a proportional increase in catalytic activity such that adenosine concentration will remain essentially constant. The catalytic activity of the enzyme will not begin to limit the rate of degradation until the substrate concentration is well above the K m of the adenosine deaminase, 29 /*M (Rockwell and Maquire, 1970) . We know of no evidence that cardiac interstitial adenosine concentrations ever attain such high levels. Accordingly, the finding that adenosine deaminase affected neither the static nor the dynamic autoregulatory flow response implies that adenosine is not essential for coronary autoregulation. Furthermore, since adenosine deaminase did not alter the coronary pressure-flow relationship when pressure was reduced below the autoregulatory range, it seems unlikely that adenosine is essential for the maintenance of coronary vasodilation at these lower perfusion pressures.
In these experiments, circumflex artery pressure was regulated independently of aortic pressure; thus, pressure gradients could have resulted in intracoronary collateral flow. Although early work by Driscol et al. (1964) demonstrated that the pattern of coronary flow in response to changes in perfusion pressure was not altered by sizeable pressure gradients between major vessels, more recent data suggest that collateral flow may influence the steady state pressure-flow relationship in the circumflex artery at low perfusion pressures . Although coronary flow may have been underestimated at the lower perfusion pressures in the present study, the gradient for collateral flow was the same before and during adenosine deaminase infusion. Thus, the failure of adenosine deaminase to alter coronary flow responses to pressure change cannot be attributed to differences in collateral flow.
Our experiments in blood perfused in situ dog hearts lead to a conclusion diametrically opposite to that reached by who studied isolated, buffer-perfused guinea pig hearts. Differences in the characteristics of autoregulation, perhaps related to the preparations or to the species, and also a fundamental difference between the experimental designs, may explain the discordant conclusions. Coronary autoregulation in the guinea pig preparation occurred between pressures of 60 and 20 cm H 2 O (44-15 mm Hg), which is below the pressure range for autoregulation which we and others have obsrved in the blood-perfused dog heart (Mosher et al., 1964; Cross, 1964; Guyton et al., 1977; Rouleau et al., 1979; Dole et al., 1981 Dole et al., , 1982 . An inverse correlation between adenosine release rate and coronary perfusion pressure in the guinea pig was the major element of support for the hypothesis that adenosine mediates coronary autoregulation. In our study, destruction of cardiac interstitial adenosine provides a direct test of the role of this nucleoside in coronary autoregulation.
Our conclusion that adenosine is not essential for coronary vasodilation following reductions in perfusion pressure is consistent with recent work by Gewirtz et al. (1983) in a closed chest conscious pig model. In that study an intracoronary infusion of adenosine deaminase had no effect on regional myocardial perfusion beyond a flow-limiting coronary stenosis which reduced post stenotic pressure to 77 mm Hg at a mean aortic pressure of 117 mm Hg. These authors point out that measurements of steady state coronary pressure and flow do not exclude the possibility that the effect of adenosine is transitory and might be essential in initiating but not maintaining coronary vasodilation. The present study shows that such is not the case, since adenosine deaminase did not alter the time course of coronary autoregulation.
A recent preliminary report by Hanley et al. (1984) also showed that adenosine deaminase does not 523 alter coronary autoregulation. In addition, these investigators estimated interstitial adenosine concentrations by means of an epicardial well technique and found that adenosine concentration was the same at high and low perfusion pressures within the plateau of the coronary pressure-flow curve.
The attenuation of canine myocardial reactive hyperemia by intracoronary adenosine deaminase in the present study confirms a previous report by Saito et al. (1981) and indicates that adenosine can account for at least 30% of the hyperemic flow following coronary occlusions >5 sec. The additional finding that adenosine deaminase had little effect on reactive hyperemia following 2-second occlusions suggests that adenosine does not play a major role in flow regulation following relatively short coronary occlusions.
There is a potential limitation to the interpretation of experiments designed to assess the contribution of a single mediator to a physiological response which is the resultant of several, interacting mediators. In such a case, blocking or destroying one mediator could elicit a compensatory increase in the contribution of another such that the response is unaltered. Accordingly, we recognize the possibility that coronary autoregulation or myocardial reactive hyperemia may result from the concerted action of adenosine and other, as yet unidentified, vasodilator mechanisms which are capable of compensating when adenosine is destroyed.
